Human streptococcal disease syndrome compared with observations in chimpanzees. II. Immunologic responses to induced pharyngitis and the effect of treatment.
D000820:Animal Diseases / Q000188:drug therapy / Q000276:immunology; D000818:Animals; D000906:Antibodies / Q000032:analysis; D000917:Antibody Formation; D000989:Antistreptolysin / Q000032:analysis; D002097:C-Reactive Protein / Q000032:analysis; D002648:Child; D004195:Disease Models, Animal; D006386:Hemagglutination Tests; D015186:Hominidae; D006801:Humans; D006821:Hyaluronoglucosaminidase; D007110:Immunity, Active; D010401:Penicillin G Benzathine / Q000627:therapeutic use; D010612:Pharyngitis / Q000188:drug therapy / Q000276:immunology*; D011233:Precipitin Tests; D012703:Serotyping; D013045:Species Specificity; D013290:Streptococcal Infections / Q000188:drug therapy / Q000276:immunology*; D013291:Streptococcus / Q000254:growth & development / Q000276:immunology
D000906:Antibodies; D000989:Antistreptolysin; D002097:C-Reactive Protein; D006821:Hyaluronoglucosaminidase; D010401:Penicillin G Benzathine